United Kingdom Imposes Mandatory National Poultry Housing Order to Counter Spreading Avian InfluenzaOn November 11, 2026, the Department for Environment, Food and Rural Affairs (Defra), alongside the UK Health Security Agency, declared a mandatory poultry housing order across England;
CDC Study Finds Drug-Resistant CP-CRE Infections Nearly Doubled in U.S. ChildrenA Centers for Disease Control and Prevention surveillance study found carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) infections among U.S.
Florida Man Pleads Guilty in 42 Million Dollar Medicare Genetic Testing and Equipment Fraud SchemeA Florida healthcare operator entered a formal guilty plea for orchestrating a sprawling fraud conspiracy that billed federal programs for unneeded medical braces and cancer tests.
United States Forfeits Measles Elimination Status as 2026 Cases Surge Past 5,412 in Landmark Health ReversalOn Friday night, November 13, 2026, the Pan American Health Organization declared that the United States has forfeited measles elimination status, ending an achievement sustained for 26 years since…
CDC Expands Bird Flu Wastewater Tracking After Fatal Human Case in WashingtonATLANTA - The Centers for Disease Control and Prevention expanded its national wastewater surveillance network on Nov.
FDA Approves Iberdomide as First CELMoD for Multiple Myeloma Following Cleveland Clinic Clinical IntegrationBetween November 12 and 13, 2026, Cleveland Clinic Consult QD and OncLive published clinical practice guidelines confirming that the United States Food and Drug Administration approved iberdomide…
CMS Finalizes Medicare Rule Setting 2027 Part D Out-of-Pocket Cap at $2,400BALTIMORE - The Centers for Medicare & Medicaid Services issued final regulatory rule CMS-4215-F on Nov. 5, establishing a $2,400 out-of-pocket cap for Medicare Part D prescription drugs in 2027.
US FDA Reportedly Shelves Fast-Track National Priority Voucher Drug Review PilotThe US Food and Drug Administration has quietly halted its Commissioner's National Priority Voucher pilot program, Reuters reported Thursday.
American Cancer Society Urges Routine Prostate Cancer Screening for Middle-Aged MenThe American Cancer Society issued its first major update to prostate cancer screening guidelines in more than a decade on Thursday, recommending routine blood testing for middle-aged men.
Novo Nordisk Files Once-Daily Oral Sickle Cell Therapy Etavopivat With US and EU RegulatorsNovo Nordisk filed for approval of etavopivat in the US and Europe, the company announced on Friday. The drug is a once-daily oral treatment for sickle cell disease.
North Carolina Secures $216.8 Million in Federal Rural Health Transformation FundingThe US Centers for Medicare & Medicaid Services (CMS) has awarded North Carolina $216,824,573.30 in continued Rural Health Transformation Program funding, state health officials announced Thursday.
Merck Receives Positive EU CHMP Opinion for WELIREG Combination in Advanced Kidney CancerPharmaceutical developer Merck announced Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization for WELIREG in combination…
US Measles Cases Surge to 5,182 in 2026 Threatening Two-Decade Elimination StatusATLANTA — Official epidemiological surveillance released by the Centers for Disease Control and Prevention on Thursday, November 12, 2026, confirmed that the United States has recorded 5,182…
CDC Reports Six Measles Deaths in 2026 as US Risks Losing Elimination StatusThe US Centers for Disease Control and Prevention reported six measles-related deaths in 2026 on Thursday. That doubles the fatality count recorded across all of 2025.
PAHO Weighs Stripping U.S. and Mexico of Measles Elimination Status Amid Rising Child TollNorth American Elimination Status Under Review International health experts convened in Washington this week under the Pan American Health Organization (PAHO) to determine whether the United States…
Google Cloud Launches Gemini for Healthcare to Streamline Clinical Records and Drug CostsSUNNYVALE, Calif. — Google Cloud officially introduced Gemini for Healthcare on Thursday, November 12, 2026, delivering an enterprise agentic software platform engineered to automate clinical…
FDA Approves Perioperative Durvalumab Plus Enfortumab Vedotin for Cisplatin-Ineligible Bladder CancerThe U.S. Food and Drug Administration on November 13, 2026, approved AstraZeneca's durvalumab combined with enfortumab vedotin-ejfv before surgery, followed by single-agent durvalumab after surgery,…
Eledon Advances Tegoprubart Toward 600-Patient Phase 3 Kidney Transplant TrialEledon Pharmaceuticals reported third-quarter 2026 financial results Thursday and confirmed its global Phase 3 LEGACY kidney transplant trial of tegoprubart remains on track to launch in the fourth…
ECDC Reports Bundibugyo Ebola Outbreak Reaches 11,114 Confirmed Cases and 5,433 Deaths in DRCThe European Centre for Disease Prevention and Control (ECDC) released an updated epidemiological surveillance report on Thursday tracking the multi-country outbreak of Bundibugyo Ebola virus disease…
CMS Awards $10 Billion Across All 50 States in Second Year of Rural Health GrantsThe Centers for Medicare & Medicaid Services (CMS) confirmed the second-year funding in its Thursday, November 12, 2026 official bulletin, distributing $10 billion across all 50 states under the…
CDC Eliminates $29 Million in Texas HIV Prevention Grants Across 13 NonprofitsAUSTIN, Texas — The CDC has cut $29 million in direct federal HIV prevention funding across Texas. It declined to renew a five-year grant program.
Cardiff Oncology Colorectal Cancer Drug Onvansertib Shows 21-Month Durability in Phase 2 TrialClinical-stage biotechnology developer Cardiff Oncology announced updated clinical data for its lead oncology compound onvansertib in patients with metastatic colorectal cancer on November 13.
AWS Commits $100 Million in Cloud and AI Credits to Expand Global Healthcare AccessAmazon Web Services (AWS) is committing $100 million in cloud computing and artificial intelligence technology credits over five years under its Health Impact Initiative.
WHO and CDC Report Global Measles Cases Surged 20% in 2023 Infecting 10.3 Million PeopleOver 22 Million Children Missed First Vaccine Dose as Global Immunization Coverage Lags WHO and CDC released joint epidemiological surveillance report on November 14, 2026, confirming global measles…
Eli Lilly SUMMIT Trial Demonstrates Tirzepatide Cuts Heart Failure Events and Cardiovascular Death by 38%Eli Lilly and Company presented Phase 3 clinical trial findings on November 16, 2026, at the American Heart Association (AHA) Scientific Sessions in Chicago, Illinois, concurrently published in the…
Study of 4,500 Older Adults Reveals Overweight at Dementia Diagnosis Cuts Mortality Risk Up to 27%Longitudinal Evaluation of 4,500 Geriatric Patients Links BMI to Survival A prospective clinical cohort study tracking 4,500 older adult patients across multiple academic medical centers published…
FDA Approves Syndax Pharmaceuticals' Revuforj as First Menin Inhibitor for Relapsed Acute LeukemiaFirst-in-Class Menin Inhibitor Disrupts Oncogenic KMT2A Protein Complex Transcription The FDA announced on November 15, 2026, approval of Revuforj (revumenib) tablets, developed by Syndax…
Phase 3 Trial Confirms Ponatinib and Blinatumomab Extend Event-Free Survival in Ph+ ALLPhase 3 Trial Establishes Survival Advantages in Adult Leukemia Clinical trial results published by the international hematology oncology group GIMEMA on November 11 established superior outcomes…
CDC Health Advisory Alerts Clinicians to Unusual Surge of Walking Pneumonia Infections in Preschool ChildrenThe Centers for Disease Control and Prevention issued a nationwide health advisory alerting pediatricians and emergency department physicians to a sharp increase in Mycoplasma pneumoniae infections,…
Mount Sinai Study in JAMA Reveals Direct-to-Consumer Drug Ads Skew Healthcare AI Clinical RecommendationsA medical informatics research team from the Icahn School of Medicine at Mount Sinai published an empirical study in JAMA Network Open on November 11, 2026, examining commercial influences across…
Merck's Investigational Oral PCSK9 Inhibitor MK-0616 Reduces LDL Cholesterol by 60% in Clinical TrialsMerck & Co. announced clinical updates on its investigational oral PCSK9 inhibitor candidate MK-0616 on November 12, 2026, from its Rahway, New Jersey, headquarters.
Henry Ford Health Clinical Trial Shows Treating Nightmares Early Reduces PTSD RiskEarly sleep intervention lowers PTSD diagnosis by 42% Led by principal investigator Dr.
Canada Confirms First Domestically Acquired Human H5N1 Avian Flu Case in British Columbia TeenagerNational Microbiology Laboratory Confirms Clade and Genotype The Public Health Agency of Canada and British Columbia health authorities confirmed November 13 that a hospitalized adolescent tested…
FDA Grants Breakthrough Device Designation to Neuralink Blindsight Visual Prosthesis ImplantNeuralink announced on November 11, 2026, in Fremont, California, that its visual cortical prosthesis, Blindsight, received Breakthrough Device Designation from the US Food and Drug Administration.
FDA Grants Accelerated Approval to PTC Therapeutics' Kebilidi for Rare Brain Genetic DiseaseDirect Stereotactic Micro-Infusions into Putamen Deliver Functional DDC Transgenes The United States Food and Drug Administration (FDA) announced on November 13, 2026, that it granted accelerated…
FDA Grants Accelerated Approval to Dato-DXd for Patients with Advanced Non-Small Cell Lung CancerThe US Food and Drug Administration (FDA) granted accelerated approval to the antibody-drug conjugate datopotamab deruxtecan (Dato-DXd) on November 11, 2026.
FDA Approves Pimicotinib Oral Kinase Inhibitor for Symptomatic Giant Cell TumorsTargeted CSF-1R Kinase Inhibitor Expands Non-Surgical Oncology Care The U.S. Food and Drug Administration granted regulatory approval for pimicotinib on November 10.
FDA Approves Pimicotinib as Novel Oral Targeted Therapy for Tenosynovial Giant Cell TumorThe United States Food and Drug Administration approved oral CSF-1R kinase inhibitor pimicotinib on November 11, 2026, for adult patients with extensive tenosynovial giant cell tumor not amenable to…
U.S. FDA Approves Bayer's Sunharbo as First Factor XIa Inhibitor for Stroke PreventionThe U.S. Food and Drug Administration has granted marketing approval to Bayer's asundexian, branded as Sunharbo, making it the first Factor XIa inhibitor cleared worldwide to prevent repeat strokes.
Eli Lilly Phase 3 SUMMIT Trial Shows Tirzepatide Cuts Heart Failure Risk by 38% in Obese AdultsEli Lilly and Company announced primary clinical endpoint results from its pivotal Phase 3 trial in Indianapolis on November 11, 2026.
Maternal Care Payment OverhaulCMS finalized its fee schedule rule, following clinical guidance from the American College of Obstetricians and Gynecologists and the American Medical Association.
ESMO Discloses Phase II Clinical Trial Results Showing 73% Disease Control Rate for Novel Bispecific Antibody in Advanced Gastrointestinal CancersDual-Targeting Mechanism Overcomes Immunosuppressive Microenvironments in Cold Solid Tumors On November 10, 2026, the European Society for Medical Oncology (ESMO) released updated clinical data from…
FDA Clears Bechtel Medical Wound VOX System Combining Negative Pressure and Topical Oxygen for Chronic WoundsBechtel Medical announced on Tuesday that its Wound VOX advanced therapy system has received 510(k) premarket clearance from the US Food and Drug Administration.
Vir Biotechnology Reports Positive Phase 3 Hepatitis Delta Trial Results for Elebsiran and Tobevibart Achieving 57% Virologic ResponsePublished: 2026-11-11 03:18 EST Vir Biotechnology announced definitive topline results from its pivotal Phase 3 clinical trial evaluating the combination of monoclonal antibody tobevibart and small…
White House Issues 2026 Veterans Day Presidential Proclamation Honoring Service and Expanding Healthcare BenefitsThe White House issued the official 2026 Veterans Day presidential proclamation on Tuesday, designating November 11 as a national day of observance across all states.
Promega OncoMate MSI System Receives FDA Approval as Universal Companion Diagnostic for PembrolizumabPromega Corporation announced on Tuesday, November 10, 2026, that its OncoMate MSI Diagnostic System has received pre-market approval from the U.S. Food and Drug Administration.
CDC Surveillance Report Reveals 92% Surge in Pediatric CP-CRE Superbug Infections Driven by NDM GeneNational Surveillance Unveils Pediatric Superbug Trajectory A landmark epidemiological investigation published by CDC researchers in the Journal of the Pediatric Infectious Diseases Society raised…
Consumer Products Giant Mars Announces $1.4 Billion Manufacturing Expansion Across US Facilities and £161 Million UK Petcare InvestmentMars Plans $1.4 Billion in Domestic Manufacturing Spending Mars, Incorporated announced on November 10, 2026, a $1.4 billion capital investment covering United States manufacturing and operations…
IASO Bio Secures Synchronized US FDA and China NMPA IND Approvals for In Vivo CAR-T Therapy IASO208IASO Bio announced synchronized investigational new drug clearances for its in vivo CAR-T therapy IASO208. The company disclosed this on Wednesday, November 11, 2026.
Google Cloud Launches Gemini Healthcare Agent Platform Integrating Read-Only EHR Data with Verato IdentityGoogle Cloud announced on Tuesday, November 10, 2026, the general commercial availability of its specialized Gemini Healthcare Agent platform for global clinical health systems.